ArteraAI Prostate Test
Localized Prostate Cancer & Biochemical Recurrence Post-Prostatectomy
Approved/CommercialActive
Key Facts
Indication
Localized Prostate Cancer & Biochemical Recurrence Post-Prostatectomy
Phase
Approved/Commercial
Status
Active
Company
About Artera
Artera is a commercial-stage diagnostics company using multimodal AI to personalize cancer therapy, starting with prostate cancer. Its FDA-authorized ArteraAI Prostate Test helps identify patients with biochemical recurrence who may benefit from intensified salvage therapy, guiding treatment decisions for clinicians. The company has established significant clinical validation, guideline inclusion, and commercial traction with over 400 institutions. Artera is expanding its platform into new cancer types, including breast cancer, positioning itself at the intersection of AI, digital pathology, and precision oncology.
View full company profile